Bristol-Myers Squibb Co is a biopharmaceutical company. It discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products.
| Website: | www.bms.com |
| Email: | john.elicker@bms.com |
| Main Phone: | +1 212 546-4000 |
| Address: | 345 Park Avenue |
| State: | NY |
| City / Town: | New York |
| Country: | USA |
| Postal Code: | 10154 |
| Exchange: | NYE |
| Employees: | 25000 |
| NAICS: | Pharmaceutical P |
| Last Price 52.30 | Change $ -0.08 | Change % -0.15 | Tick N/A |
| Bid 52.01 | Bid Size 200.00 | Ask 53.64 | Ask Size 100.00 |
| Open 52.35 | High 52.85 | Low 52.04 | Prev Close 52.38 |
| Last Trade | Volume 14.7 mi | 52 Wk Hi 70.05 | 52 Wk Low 51.56 |
| Market Cap 85.5 bi | Ex-Div Date | Div Rate 1.60 | Yield 3.0590 |
| Shares 1,635,024,314.00 | EPS (TTM) 0.60 | PE Ratio 87.30 | Exchange NYSE |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 17 | 275 |
| Number of Buys | 5 | 131 |
| Number of Sells | 12 | 144 |
| Net Activity | -53404 | 173997 |
| Last 10 Buys | Shares |
|---|---|
| N/A | 0 |
| Last 10 Sell | Shares |
|---|---|
| Lamberto Andreotti | 1,000 |
| Lamberto Andreotti | 1,000 |
| Lamberto Andreotti | 1,000 |
| Lamberto Andreotti | 1,000 |
| Lamberto Andreotti | 1,000 |
| Lamberto Andreotti | 1,000 |
| Lamberto Andreotti | 1,000 |
| John E. Elicker | 1,000 |
| Charles A. Bancroft | 1,000 |
| Joseph C. Caldarella | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 100 | 100 | 100 | 100 |
| Low Target Price Estimate | 48 | 48 | 48 | 48 |
| Mean Target Price Estimate | 70.21 | 70.21 | 74.71 | 68.38 |
| Standard Deviation | 13.06 | 13.06 | 13.79 | 12.94 |
| Date of Most Recent Estimate | 08/08/16 | 08/08/16 | 07/29/16 | 08/19/16 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-03 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 368 | 2016-07-28 |
| 8-K | Report of unscheduled material events or corporate changes. | 34 | 2016-07-28 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-11 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-06 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-06 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-06 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-05 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-05 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-05 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 5 | 7 | 7 | 7 |
| Moderate Buy | 0 | 1 | 1 | 1 |
| Hold | 10 | 7 | 7 | 7 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 2 | 2 | 2 | 2 |
| Mean Rec. | 2.65 | 2.32 | 2.32 | 2.32 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
